Free Cancer Screening for DoD Firefighters

Full Title:
Federal Firefighter Cancer Detection and Prevention Act of 2025

Summary#

This bill would require the Department of Defense (DoD) to offer free cancer screening and related services to its firefighters. The screenings must be provided during the annual periodic health assessment or at other clinically indicated times. The bill aims to detect, document, and help prevent cancers that are more common in firefighters.

  • Main change: DoD must provide, at no cost to the firefighter, specified screenings for breast, colon, prostate, and other cancers identified as higher risk for firefighters.
  • Who pays: The bill requires DoD to provide the services; it does not state a new funding source.
  • Data and privacy: DoD must document test acceptance and results, remove personal identifiers before analysis, and may share de-identified data with the CDC.
  • Choice: Firefighters may opt out of any test or service.
  • Standards: Tests must follow consensus technical standards.

What it means for you#

  • DoD firefighters

    • The DoD must offer free cancer screenings during the annual health check or as clinically needed.
    • Female firefighters are to be offered mammograms: at least every two years for ages 40–49, yearly at 50+, and as clinically indicated regardless of age.
    • Firefighters 40+ get information on stool-based colon tests; those 45+ get regular visual exams (colonoscopy, CT colonoscopy, sigmoidoscopy) or stool tests as clinically indicated.
    • Male firefighters are to get information on prostate screening risks/benefits and an annual PSA test at age 50+, and at 40+ if high-risk; testing also as clinically indicated.
    • Firefighters can decline any test (opt out).
  • DoD medical staff and clinics

    • Must provide the screenings, have licensed radiologists or physicians review and report results, and follow consensus technical standards.
    • Must document acceptance rates and test results and remove personal identifiers before analysis.
  • Centers for Disease Control and Prevention (CDC)

    • May receive de-identified test data from DoD to study cancer patterns in firefighters.
  • General public / taxpayers

    • The program would be run by DoD health services and could affect DoD health budgets or staffing needs.
  • Who is included

    • The bill applies to “firefighters” as defined in an earlier law (the National Defense Authorization Act for Fiscal Year 2020). It is not explicit in the bill text which specific categories (active duty, civilian DoD employees, contractors) are covered; that depends on that earlier definition.

Expenses#

No publicly available information.

  • The bill does not include a fiscal note or specific funding source in the text provided.
  • This could mean added DoD costs for screening tests, radiologist and physician time, lab work, follow-up care, data collection, and reporting systems.
  • There could be administrative costs to track acceptance rates, de-identify data, and share data with the CDC.
  • There may be offsetting savings if earlier detection reduces later treatment costs, but the bill does not analyze that.

Proponents' View#

  • The bill appears intended to detect and document cancers earlier among DoD firefighters and to reduce cancer harms.
  • It would standardize screening practices for several cancers known to be higher risk in firefighters.
  • The bill would create a data stream to better understand cancer rates in firefighters by documenting tests and sharing de-identified data with the CDC.
  • Making tests free removes a financial barrier for eligible firefighters.

Opponents' View#

  • One concern is the lack of a stated funding source; the bill does not explain how DoD will pay for the added tests, staffing, and data work.
  • The definition of “firefighter” is referenced but not restated; it may be unclear which DoD personnel are covered without checking the earlier law.
  • The bill allows opt-outs; this could lower participation and reduce the value of the data and prevention goals.
  • The term “high-risk” for prostate cancer leaves room for broad Secretary discretion, which could create inconsistent application.
  • The bill requires data sharing with the CDC but does not detail safeguards beyond removing names; it is unclear how privacy and re-identification risks will be managed.
  • The bill does not specify whether follow-up care or treatment for positive screening results is covered, or how care coordination will work after detection.